Many bioentrepreneurs incorrectly estimate the value of their technology by failing to account adequately for the cost, risk, ...

SANA develops engineered cell therapies for diabetes, autoimmune diseases, and cancer using ex vivo HIP and in vivo fusogen platforms. SC291 is their CD19‑targeted allogeneic CAR-T candidate which ...

If only the human body could handle trauma as well as biotechnology stocks do. - Alex Berenson. The biotechnology sector has been a hotbed of innovation with companies in the industry pushing the ...

Biotech stocks have a way of making smart people do dumb things. It starts innocently enough. You read about a "breakthrough" that sounds like it came straight out of science fiction. A tiny company ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001. What Are Smart Beta ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...

There's a beaten-down biotech that may be worth the shot. The biotech sector has been on fire as of late. The SPDR S & P Biotech ETF (XBI) is up 25% year-to-date and trading at 52-week highs. It ...

Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to ...